Finance · Corrected
Pfizer Raises Its 2026 Forecast as Eliquis and Cancer Drugs Offset Falling Covid Sales
Fact checked by NewsPlainVerified by NewsPlain: confirmed by at least two named sources
Brief
Pfizer raised its 2026 forecast on Tuesday after a third quarter in which Eliquis and several cancer drugs nearly made up for steep drops…
Keep reading with NewsPlain Premium
Get the full brief, the full story, what's confirmed, what's still unclear, why it matters, and every source.
4 sources behind this story.
Updates
Correction, : The $135 million, or 33%, increase covers combined global Nurtec ODT and Vydura sales. The reported sales declines for Paxlovid, Comirnaty and the Prevnar family exclude currency effects.